Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration (wAMD)”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Large-scale testing (Phase 3)UnknownNCT04572698
What this trial is testing

Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Who this might be right for
Age Related Macular Degeneration
Luye Pharma Group Ltd. 416
Early research (Phase 1)UnknownNCT04468997
What this trial is testing

The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 67
Not applicableStudy completedNCT01899963
What this trial is testing

Time to Treatment Utilizing a Tele-Retinal Referral System for wAMD and DME: A Pilot Study

Who this might be right for
Wet Age Related Macular DegenerationDiabetic Macular Edema
McMaster University 83
Post-approval studies (Phase 4)Study completedNCT01896284
What this trial is testing

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Who this might be right for
Wet Macular Degeneration
Barcelona Macula Foundation 46
Large-scale testing (Phase 3)Study completedNCT05345236
What this trial is testing

Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Qilu Pharmaceutical Co., Ltd. 366
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06839339
What this trial is testing

Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT03861234
What this trial is testing

Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Macular Degeneration
Boehringer Ingelheim 43
Not applicableStudy completedNCT03470103
What this trial is testing

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

Who this might be right for
Macular Degeneration
Bayer 643
Large-scale testing (Phase 3)Study completedNCT04964089
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 557
Testing effectiveness (Phase 2)Study completedNCT03558074
What this trial is testing

Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Alkahest, Inc. 26
Large-scale testing (Phase 3)Looking for participantsNCT06864988
What this trial is testing

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Macular Neovascularization Secondary to Age-Related Macular Degeneration
4D Molecular Therapeutics 480
Not applicableStudy completedNCT01269151
What this trial is testing

Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD

Who this might be right for
Age-Related Macular DegenerationRetinal Function
University of Luebeck 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06668064
What this trial is testing

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

Who this might be right for
Wet Age Related Macular DegenerationwAMD
EyePoint Pharmaceuticals, Inc. 400
Not applicableLooking for participantsNCT06346600
What this trial is testing

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics 83
Testing effectiveness (Phase 2)Study completedNCT05381948
What this trial is testing

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
EyePoint Pharmaceuticals, Inc. 161
Testing effectiveness (Phase 2)Study completedNCT04832724
What this trial is testing

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular DegenerationWet Age-related Macular Degeneration
AbbVie 60
Not applicableLooking for participantsNCT06859515
What this trial is testing

A Long-term Follow up Study of EXG102-031 in Participants With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Hangzhou Jiayin Biotech Ltd 42
Early research (Phase 1)Study completedNCT03748784
What this trial is testing

ADVM-022 Intravitreal Gene Therapy for Wet AMD

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 30
Large-scale testing (Phase 3)Looking for participantsNCT04704921
What this trial is testing

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+6 more
AbbVie 630
Not applicableActive Not RecruitingNCT06518512
What this trial is testing

Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD Patients

Who this might be right for
Age-Related Macular DegenerationWet Age-related Macular Degeneration
Tan Tock Seng Hospital 128
Load More Results